Axenoll Life Sciences AG is a Swiss medical technology company based in Zurich, Switzerland. The company was founded in 2014 and has a 100%-owned subsidiary in Jena, Axenoll 3D Printing GmbH, which serves as the operational unit.

Axenoll focuses on the 3D printing of biomaterials for applications in the medical and biotechnological fields. The 3D screen printing technology enables the production of high quantities of identical items with nearly unrestricted material choice and the combination of materials in different layers. Axenoll's portfolio includes a wide range of 3D products such as wound dressings, screening chips, and scaffolds for complex cell models.

For more information, please visit: www.axenoll.com